Arrowstreet Capital, Limited Partnership Ac Immune Sa Transaction History

Arrowstreet Capital, Limited Partnership

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $230,463 - $360,725	-47,715 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$6.04 - $8.37 $485,513 - $672,805	-80,383 Reduced 62.75%	47,715 $378,000
Q1 2021 May 14, 2021	BUY	$5.32 - $8.96 $7,400 - $12,463	1,391 Added 1.1%	128,098 $975,000
Q4 2020 Feb 12, 2021	SELL	$4.47 - $5.58 $336,197 - $419,682	-75,212 Reduced 37.25%	126,707 $655,000
Q3 2020 Nov 12, 2020	BUY	$4.78 - $9.06 $2,868 - $5,436	600 Added 0.3%	201,919 $985,000
Q1 2020 May 15, 2020	BUY	$4.24 - $9.89 $788,296 - $1.84 Million	185,919 Added 1207.27%	201,319 $1.39 Million
Q4 2019 Feb 13, 2020	BUY	$4.56 - $8.78 $70,224 - $135,212	15,400 New	15,400 $131,000
Q4 2018 Feb 14, 2019	SELL	$7.35 - $11.7 $159,083 - $253,234	-21,644 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$7.88 - $16.45 $170,554 - $356,043	21,644 New	21,644 $173,000

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $233M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.